Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Insulet, DexCom team up for diabetes technology:

This article was originally published in Clinica

Executive Summary

Insulin pump manufacturer Insulet has combined with DexCom, a specialist in making glucose monitoring systems, in order to integrate the latter's technology into Insulet's handheld OmniPod system personal diabetes manager (PDM). The non-exclusive agreement sees San Diego, California-based DexCom provide Insulet with access to its continuous glucose monitoring technology, which when incorporated into the PDM, will allow diabetic patients to access real-time glucose values and receive alarms concerning high or low glucose levels. The two companies will develop the product over 2008, with product launch expected in mid-2009.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT045736

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel